We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 Guidance ROCKVILLE, MD, November 6, 2024 — MaxCyte, Inc. (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering...
MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.02 | -0.574712643678 | 3.48 | 3.48 | 3.18 | 217 | 3.33230769 | DE |
4 | 0.24 | 7.45341614907 | 3.22 | 3.48 | 3.18 | 188 | 3.31733333 | DE |
12 | 0.02 | 0.581395348837 | 3.44 | 3.58 | 3.18 | 285 | 3.40791423 | DE |
26 | -1.12 | -24.4541484716 | 4.58 | 4.66 | 3.18 | 237 | 3.65580281 | DE |
52 | -1.0999999 | -24.1228053536 | 4.5599999 | 4.66 | 3.18 | 307 | 4.01706002 | DE |
156 | 1.08 | 45.3781512605 | 2.38 | 4.66 | 2.38 | 467 | 3.67943979 | DE |
260 | 1.08 | 45.3781512605 | 2.38 | 4.66 | 2.38 | 467 | 3.67943979 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions